These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy. Myslivecek M; Nekula J; Bacovsky J; Scudla V; Koranda P; Kaminek M Nucl Med Rev Cent East Eur; 2008; 11(1):12-6. PubMed ID: 19173182 [TBL] [Abstract][Full Text] [Related]
30. Dynamic scintigraphy of bone and bone marrow in multiple myeloma patients with bone-marrow transplants. Agren B; Rudberg U; Aspelin P Acta Radiol; 1997 Jul; 38(4 Pt 1):533-8. PubMed ID: 9240673 [TBL] [Abstract][Full Text] [Related]
31. 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS. Giovanella L; Taborelli M; Ceriani L; Zucca E; Cavalli F; Delaloye AB Nucl Med Commun; 2008 Jun; 29(6):535-41. PubMed ID: 18458600 [TBL] [Abstract][Full Text] [Related]
32. Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi. Mariani G; Filocamo M; Giona F; Villa G; Amendola A; Erba P; Buffoni F; Copello F; Pierini A; Minichilli F; Gatti R; Brady RO J Nucl Med; 2003 Aug; 44(8):1253-62. PubMed ID: 12902415 [TBL] [Abstract][Full Text] [Related]
33. Technetium 99m sestamibi in multiple myeloma. Pace L; Del Vecchio S; Salvatore M Radiology; 2005 Jan; 234(1):312-3; author reply 313. PubMed ID: 15618389 [No Abstract] [Full Text] [Related]
34. Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells. Ak I; Aslan V; Vardareli E; Gülbaş Z Ann Hematol; 2003 Feb; 82(2):88-92. PubMed ID: 12601486 [TBL] [Abstract][Full Text] [Related]
35. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma. Fonti R; Del Vecchio S; Zannetti A; De Renzo A; Di Gennaro F; Catalano L; Califano C; Pace L; Rotoli B; Salvatore M Eur J Nucl Med; 2001 Feb; 28(2):214-20. PubMed ID: 11303893 [TBL] [Abstract][Full Text] [Related]
36. 99mTc-sestaMIBI scintigraphy in thalidomide-treated refractory or relapsed multiple myeloma patients. Andretta C; Catalano L; Pace L; Fonti R; Annunziata G; Rotoli B Leuk Lymphoma; 2003 Jun; 44(6):1081-2. PubMed ID: 12854916 [No Abstract] [Full Text] [Related]
37. Technetium-99m sestamibi scintigraphy in monitoring patients with multiple myeloma. Pinto AM; Califano C; Di Gennaro F; De Renzo A; Catalano L; Pace L Haematologica; 2000 Sep; 85(9):1000-1. PubMed ID: 10980649 [No Abstract] [Full Text] [Related]
38. C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy of Multiple Myeloma Using [ Enke JS; Reitsam NG; Grosser B; Kircher M; Dierks A; Bundschuh RA; Wienand G; Uhrmacher L; Trepel M; Schottelius M; Lapa C; Pfob CH J Nucl Med; 2024 Jan; 65(1):163-164. PubMed ID: 37709537 [No Abstract] [Full Text] [Related]
39. Discordant uptake on Ga-67 and Tc-99m MDP scintigraphy in a patient with multiple myeloma: an indication of poor prognosis. Li T; Farinhas J; Chun KJ; Freeman LM Clin Nucl Med; 2003 Apr; 28(4):322-4. PubMed ID: 12642716 [No Abstract] [Full Text] [Related]
40. Guidelines for the use of imaging in the management of myeloma. D'Sa S; Abildgaard N; Tighe J; Shaw P; Hall-Craggs M Br J Haematol; 2007 Apr; 137(1):49-63. PubMed ID: 17359371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]